Intracoronary epinephrine can significantly impact no-reflow in primary PCI after failure of other strategies: a novel effective therapy

Posted on by siriomedicine Posted in SIRIO MEDICINE

The RESTORE-SIRIO study showed that as compared to use of conventional agents alone, Intracoronary epinephrine provides substantial improvement of coronary flow in STEMI patients with refractory no-reflow during PPCI that may result into improved prognosis. Catheter Cardiovasc Interv. 2020 Jul 17.

.

Advertisement